Trans-Resveratrol Attenuates High Fatty Acid-Induced P2X7 Receptor Expression and IL-6 Release in PC12 Cells: Possible Role of P38 MAPK Pathway
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trans-Resveratrol Attenuates High Fatty Acid-Induced P2X7 Receptor Expression and IL-6 Release in PC12 Cells: Possible Role of P38 MAPK Pathway
Authors
Keywords
resveratrol, high fatty acids, P2X7 receptor, P38, IL-6
Journal
INFLAMMATION
Volume 38, Issue 1, Pages 327-337
Publisher
Springer Nature
Online
2014-10-27
DOI
10.1007/s10753-014-0036-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling
- (2014) Y. Han et al. EUROPEAN JOURNAL OF PAIN
- High fatty acids modulate P2X7 expression and IL-6 release via the p38 MAPK pathway in PC12 cells
- (2013) Hong Xu et al. BRAIN RESEARCH BULLETIN
- Lipid-Core Nanocapsules Improve the Effects of Resveratrol Against Aβ-Induced Neuroinflammation
- (2013) Rudimar L. Frozza et al. Journal of Biomedical Nanotechnology
- Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats
- (2013) Prabhakar Orsu et al. JOURNAL OF NEURAL TRANSMISSION
- Physiological Roles and Potential Therapeutic Applications of the P2X7 Receptor in Inflammation and Pain
- (2013) Luiz Alves et al. MOLECULES
- Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6
- (2012) T.E. Nelson et al. BRAIN BEHAVIOR AND IMMUNITY
- The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain
- (2012) Rómeó D. Andó et al. BRAIN RESEARCH BULLETIN
- P2X7 Receptors: Channels, Pores and More
- (2012) C. Volonte et al. CNS & Neurological Disorders-Drug Targets
- Fatty Acids - Induced Lipotoxicity and Inflammation
- (2012) Stephane Savary et al. CURRENT DRUG METABOLISM
- Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
- (2012) Fei Li et al. CURRENT PHARMACEUTICAL DESIGN
- IL-6 and PACAP Receptor Expression and Localization after Global Brain Ischemia in Mice
- (2012) Tomoya Nakamachi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Resveratrol Protects Cortical Neurons against Microglia-mediated Neuroinflammation
- (2012) Feng Zhang et al. PHYTOTHERAPY RESEARCH
- Nrf2 and NF-κB Modulation by Sulforaphane Counteracts Multiple Manifestations of Diabetic Neuropathy in Rats and High Glucose-Induced Changes
- (2011) Geeta Negi et al. CURRENT NEUROVASCULAR RESEARCH
- The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia
- (2010) S. A. Friedle et al. GLIA
- Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
- (2010) Albert Y. Sun et al. MOLECULAR NEUROBIOLOGY
- Effect of Resveratrol on Gliotransmitter Levels and p38 Activities in Cultured Astrocytes
- (2010) Hao Zhou et al. NEUROCHEMICAL RESEARCH
- Protective potential of trans-resveratrol against 4-hydroxynonenal induced damage in PC12 cells
- (2010) M.A. Siddiqui et al. TOXICOLOGY IN VITRO
- Insulin resistance, lipotoxicity and endothelial dysfunction
- (2009) Helen Imrie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
- (2009) A. M. Vincent et al. DIABETES
- P2X7: a growth-promoting receptor—implications for cancer
- (2009) Francesco Di Virgilio et al. Purinergic Signalling
- Differential regulation of the endoplasmic reticulum stress response in pancreatic β-cells exposed to long-chain saturated and monounsaturated fatty acids
- (2008) Eleftheria Diakogiannaki et al. JOURNAL OF ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started